The article discusses the growth of India's pharmaceutical exports despite recent challenges, such as deaths linked to Indian-made cough syrups in some countries.
India's pharmaceutical exports are expected to reach $27 billion in the current fiscal year, growing almost twice as fast as the previous year.
The robust forecast is primarily driven by strong demand in the US market, where India holds a significant share of the pharmaceutical market.
The World Health Organization linked cough syrup-related deaths to drugs made in India, raising concerns about the country's pharmaceutical products.
Despite these concerns, India remains a major player in the global pharmaceutical industry, and its size and reputation make it a significant player for global buyers.
Pharmaceutical exports from India rose by 3.25% in the previous fiscal year, reaching $25.4 billion, and are expected to grow by approximately 6.3% in the current fiscal year, reaching $27 billion.
The US market accounts for 30% of India's overall pharmaceutical exports and experienced a growth of 6.2% in the previous fiscal year, reaching $7.5 billion.
India's strong demand for drugs related to central nervous system conditions, cardiovascular issues, and oncology is contributing to the overall growth in pharmaceutical exports.
Delegations from Pharmaceuticals Export Promotion Council of India (Pharmexcil) have visited various countries to address concerns and reinforce the quality of Indian drugs.
Despite mandatory testing of cough syrups for exports in both India and Gambia, exports of cough syrups from India remain relatively unchanged, valued at around $15 million annually.
India is known for producing quality drugs at an affordable price, which has been a significant advantage for the country in the pharmaceutical industry.
In Summary
In summary, India's pharmaceutical exports are thriving, primarily due to strong demand in the US market, despite concerns related to cough syrups and quality issues in some countries. India's reputation and size in the global pharmaceutical industry continue to make it a major player.
Source Quality APIs & Formulations
Pharmgenity supplies affordable, high-quality pharmaceutical products trusted by buyers across global markets.
We Have Answers
Quick answers about India's pharmaceutical export growth and quality outlook.
India's pharmaceutical exports are expected to reach $27 billion in the current fiscal year, growing by approximately 6.3% and almost twice as fast as the previous year.
The US market. It accounts for 30% of India's overall pharmaceutical exports and experienced a growth of 6.2% in the previous fiscal year, reaching $7.5 billion.
The World Health Organization linked cough syrup-related deaths to drugs made in India. Despite mandatory testing of cough syrups in both India and Gambia, exports of cough syrups from India remain relatively unchanged at around $15 million annually.
Delegations from the Pharmaceuticals Export Promotion Council of India (Pharmexcil) have visited various countries to address concerns and reinforce the quality of Indian drugs.
India is known for producing quality drugs at an affordable price, and its size and reputation make it a significant player for global buyers.